Bill · 119th Congress
H.R. 10369
Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026
- 01 Introduced
- 02 Committee
- 03 Passed House
- 04 Passed Senate
- 05 To President
- 06 Law
Latest action · Sep 14, 2026
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
What this bill does
No summary yet
How Congress voted
No recorded votes yet. Many bills pass by voice vote or unanimous consent, where no one's individual vote is written down.
Timeline
- Sep 14, 2026Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Sep 14, 2026Introduced in House
Cosponsors
4 members
- Rick W. AllenR-GA-12
- Jake AuchinclossD-MA-4
- Lucy McBathD-GA-6
- Carol D. MillerR-WV-1
Details
Related bills
None listed
Cost estimates · Congressional Budget Office
None published